You are here: Industry Insights > Diabetes

News List

Preventing Type 2 Diabetes with Proven Program, Free in Hudson, Ohio biospace
March 15, 2018
GemCare Wellness is offering the PreventT2 lifestyle change program for free to community members to help prevent or delay the onset of type 2 diabetes
CBD may help curb frequency of epileptic seizures europeanpharmaceuticalreview
March 09, 2018
A naturally occurring compound found in cannabis may help to curb the frequency of epileptic seizures…
Study reveals "concerning" low standards of type 2 diabetes drugs in India pharmafile
March 08, 2018
The Indian regulatory system, particularly type 2 diabetes, allows the use of drugs that have not been proven to be safe and effective, far behind the standards set by the World Health Organization.
Physician Group Releases Less Stringent Guidance for Type 2 Diabetes Care biospace
March 07, 2018
Maintaining control of blood sugar levels has been a hallmark of diabetes maintenance for millions of patients.
Study identifies five kinds of diabetes, potentially changing treatment pharmafile
March 05, 2018
A decade-long study has unearthed findings that could entirely change how people living with diabetes are treated, after the classic distinction between type 1 and 2 diabetes was shown to need some revision.
Unique pancreatic stem cells have potential to regenerate beta cells, respond to glucose worldpharmanews
March 01, 2018
Scientists from the Diabetes Research Institute at the University of Miami Miller School of Medicine have confirmed the existence of progenitor cells within the human pancreas that can be stimulated to develop into glucose-responsive beta cells.
Aspirin lowers risk of death for patients with diabetes and heart failure europeanpharmaceuticalreview
March 01, 2018
Researchers assess aspirin as a preventive measure for patients who have both diabetes and heart failure…
Novo Nordisk’s diabetes pill presents the first successful data biospectrumasia
February 27, 2018
The oral form of the drug, known generically as semaglutide, is crucial for ensuring the group's long-term growth, as price pressure mounts in a crowded market targeting the world's 450 million diabetics.
Semaglutide Demonstrated Significant Reductions in Blood Sugar and Weight Compared with Dulaglutide; prnasia
February 02, 2018
The Lancet Diabetes and Endocrinology has published the results of the SUSTAIN 7 trial
New Player Joining, what will be Its Odds of Success in Marching into the Hypoglycemic Drug Market? Xiaoyaowan
January 23, 2018
New Player Joining the Chinese Class 1 New Drugs of DPP-4 Inhibitor Type, what will be Its Odds of Success in Marching into the Hypoglycemic Drug Market?

Previous page 1 2 3 4 5 6 7 8 9 10 ... 37 38 Next page